Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,350 GBX | +0.37% | -6.25% | +13.67% |
05-16 | Secure Trust Bank rises on first quarter | AN |
05-08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 350.1 | 298.8 | 329.8 | 328.9 | 424.4 | 475.6 | - | - |
Enterprise Value (EV) 1 | 709.6 | 585.2 | 664.1 | 686.1 | 804.6 | 832.3 | 815.3 | 793.8 |
P/E ratio | - | 10.7 x | 6.84 x | -21.7 x | 8.02 x | 8.93 x | 8.32 x | 7.21 x |
Yield | 2.46% | 5.97% | 5.69% | 6.08% | 4.63% | 5.18% | 5.38% | 5.63% |
Capitalization / Revenue | 1.08 x | 1.18 x | 1.1 x | 0.92 x | 1.1 x | 1.11 x | 1.01 x | 0.92 x |
EV / Revenue | 2.19 x | 2.31 x | 2.21 x | 1.92 x | 2.09 x | 1.95 x | 1.73 x | 1.53 x |
EV / EBITDA | 5.95 x | 5.99 x | 5.41 x | 4.79 x | 5.16 x | 4.58 x | 4.08 x | 3.56 x |
EV / FCF | - | - | - | 25.1 x | 15.7 x | 18.4 x | 23 x | 19.3 x |
FCF Yield | - | - | - | 3.98% | 6.35% | 5.44% | 4.34% | 5.19% |
Price to Book | - | - | 0.73 x | 0.51 x | - | 2.29 x | 2.23 x | 2.17 x |
Nbr of stocks (in thousands) | 35,363 | 35,363 | 35,363 | 35,363 | 35,363 | 35,363 | - | - |
Reference price 2 | 9.900 | 8.450 | 9.325 | 9.300 | 12.00 | 13.45 | 13.45 | 13.45 |
Announcement Date | 3/13/20 | 3/15/21 | 3/24/22 | 3/24/23 | 3/22/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 324.6 | 253.8 | 300.3 | 357.1 | 384.1 | 427.6 | 471.7 | 518.5 |
EBITDA 1 | 119.2 | 97.62 | 122.7 | 143.2 | 155.9 | 181.6 | 200 | 222.9 |
EBIT 1 | 75.88 | 61.21 | 85.35 | 90.91 | 99.25 | 123.2 | 140.4 | 162.1 |
Operating Margin | 23.38% | 24.12% | 28.43% | 25.46% | 25.84% | 28.81% | 29.76% | 31.27% |
Earnings before Tax (EBT) 1 | - | 53.65 | 83.62 | 30.94 | 103.2 | 124.5 | 140.9 | 164.6 |
Net income 1 | - | 27.85 | 48.24 | -15.15 | 52.92 | 53.26 | 57.17 | 66.02 |
Net margin | - | 10.97% | 16.07% | -4.24% | 13.78% | 12.45% | 12.12% | 12.73% |
EPS 2 | - | 0.7877 | 1.364 | -0.4284 | 1.497 | 1.507 | 1.616 | 1.866 |
Free Cash Flow 1 | - | - | - | 27.32 | 51.13 | 45.29 | 35.4 | 41.22 |
FCF margin | - | - | - | 7.65% | 13.31% | 10.59% | 7.5% | 7.95% |
FCF Conversion (EBITDA) | - | - | - | 19.08% | 32.8% | 24.93% | 17.7% | 18.49% |
FCF Conversion (Net income) | - | - | - | - | 96.61% | 85.03% | 61.92% | 62.44% |
Dividend per Share 2 | 0.2436 | 0.5041 | 0.5308 | 0.5652 | 0.5556 | 0.6962 | 0.7238 | 0.7574 |
Announcement Date | 3/13/20 | 3/15/21 | 3/24/22 | 3/24/23 | 3/22/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 360 | 286 | 334 | 357 | 380 | 357 | 340 | 318 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.016 x | 2.934 x | 2.724 x | 2.495 x | 2.439 x | 1.964 x | 1.699 x | 1.427 x |
Free Cash Flow 1 | - | - | - | 27.3 | 51.1 | 45.3 | 35.4 | 41.2 |
ROE (net income / shareholders' equity) | - | - | 11.1% | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 12.70 | 18.30 | - | 5.870 | 6.030 | 6.190 |
Cash Flow per Share 2 | - | 0.8700 | 1.420 | 2.220 | - | 2.420 | 2.470 | 2.700 |
Capex 1 | 69.1 | 42 | 35.9 | 51.1 | 52.6 | 44.7 | 56.7 | 60.7 |
Capex / Sales | 21.28% | 16.56% | 11.96% | 14.31% | 13.69% | 10.46% | 12.02% | 11.7% |
Announcement Date | 3/13/20 | 3/15/21 | 3/24/22 | 3/24/23 | 3/22/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.67% | 603M | |
+30.39% | 34.8B | |
+13.27% | 17.9B | |
0.00% | 13.47B | |
+13.03% | 7.85B | |
-14.11% | 7.51B | |
+33.57% | 6.96B | |
+24.36% | 6.34B | |
+9.77% | 6.29B | |
+8.64% | 4.26B |
- Stock Market
- Equities
- OCN Stock
- Financials Ocean Wilsons Holdings Limited